medigraphic.com

1998, Number 3

Rev Mex Pediatr 1998; 65 (3)

Antiepilépticos en pediatría: viejos medicamentos (Primera parte)

López HJF, Pérez ZMÁ, Aguilar RF

Language: Spanish
References: 31
Page: 128-135
PDF size: 137.59 Kb.


ABSTRACT

New and old antiepileptic drugs. Update. The prevalence of seizures in the pediatric population in Mexico is about 1.2%. The morbility and prevention the neurologic damage required of knowledge of classification from LICE rice in 1989. This information is important for early diagnosis and correct treatment. This information about new and old antiepileptic drugs colateral effects, interaction between new and old are important for better understanding of him problem in pediatric epileptic patients.


REFERENCES

  1. Brodie M, Dichter M. Antiepileptic Drugs. N Engl J Med 1996; 334: 168-75.

  2. Hauser W. The Prevalence and Incidence of Convulsive Disorders in Children. Epilepsia, 1994; 35(suppl. 2): S1-S6.

  3. Martínez J, Sánchez S, Márquez L, Rivera J. Tratamiento del estado epiléptico en niños. Bol Med Hosp infant Mex 1993; 50: 129-35.

  4. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for Revised Clinical and electroencephalographic classification of Epileptic Seizures. Epilepsia 1981; 22: 489-501.

  5. Proposal for revised classification of Epilepsies and Epileptic Syndromes: Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30: 389-99.

  6. Brodie MJ, Feely J. Practical clinical pharmacology Therapeutic drug monitoring and clinical trials. Br Med J 1988; 296: 1110-14.

  7. Dreifuss F. Prognosis of Childhood Seizure Disorders: Present and Future. Epilepsia 1994; 35(suppl. 2): S30-S34.

  8. Dodrill C. Problems in the Assessment of Cognitive. Effects of Antiepileptic Drugs. Epilepsia 1992; 33 (suppl. 6): S29-S32.

  9. Bourgeois B. Pharmacologic Intervention and Treatment of childhood Seizure Disorders: Relative Efficacy and Safety of Antiepileptic Drugs. Epilepsia 1996; 35 (suppl. 2): S18-S23.

  10. Dichter M, Brodie M. New Antiepileptic Drugs. N Engl J Med 1996; 1583-90.

  11. Legido A. Neurotransmisores y Desarrollo Cerebral. Efectos Fisiólogicos y Fisiopatológicos. Acta Neuropediatr 1996; 2: 94-115.

  12. Fejerman N, Medina C. Criterios Clínicos en el Tratamiento Medicamentoso de las Epilepsias. En: Fejerman N, Medina C, ed. Convulsiones en la Infancia. Buenos Aires. El Ateneo, 1990; 22: 318-35.

  13. Vasconcelos D, Lombardo L. Clasificación y Tratamiento de las Crisis Epilépticas. Conceptos actuales. Rev Med IMSS Mex 1983; 21: 1275-86.

  14. Painter M, Gaus L. Phenobarbital. En: Elaine W, ed. The treatment of Epilepsy: Principles and practice. Filadelfia-London: Lea and Febiger 1993; 76: 909-14.

  15. Wolf S, Forysthe A, Alastair P, Studen A, Friedman R. Long-Term Effect of Phenobarbital on Cognitive Function in Children with Febrile Convulsions. Pediatics 1981; 68: 820-3.

  16. Farwell J, Jack Y, Deborah D, Hirtz G, Sulzbacher S. Phenobarbital for Febrile Seizures-Effects on Intelligence and on Seizure recurrence. N Engl J Med 1990; 322: 364-9.

  17. Wilder B, McLean J, Uthman B. Phenytoin. En: Elaine W, ed. The treatment of Epilepsy: Principles and practice. Filadelfia-London: Lea and Febiger 1993; 74: 887-99.

  18. Richard M, Chiron C, Athis P, Rey E, Aubuorg P. Pehntytoin Monitoring in status Eplipticus in Infants and Children. Epilepsia 1993; 34: 144-9.

  19. Benvenuti F, Bandinelli S, Mencarelli A, Lunardelli M, Campostrini R. Alterations of Ballistic Movements En: Epileptic Patients with Phenytoin intoxication. Epilepsia 1992; 33: 376-86.

  20. Matti Sillanpaa. Carbamazepine. En: Elaine Wyllie, ed. The Treatment of Epilepsy: Principles an Practices. Philadelphia, Lea and Febiger 1993; 76: 867-86.

  21. Jukka V, Valtonen M. Carbamazepine-Induced Eosinophillic colitis. Epilepsia 1992; 33: 119-21.

  22. Iyer V, Holmes W, Richardson R. Intractable Diarrhea from Carbamazepine. Epilepsia 1992; 33: 185-7.

  23. Robertson P, Garofalo E, Silverstein F, Komarynski M. Carbamazepine-Induced Tics. Epilepsia 1993; 34: 965-7.

  24. Bourgeois B. Primidone. En: Elaine W, ed. The treatment of Epilepsy: Principles and practice. Filadelfia-London. Lea and Febiger 1993; 76: 909-14.

  25. Dean J. Valproate. En: Elaine W, ed. The treatment of Epilepsy: Principles and practice. Filadelfia-London: Lea and Febiger, 1993; 77: 915-22.

  26. May R, Sunder T. Hematologic Manifestations of Long-Term Valproate Teraphy. Epilepsia 1993; 14: 1098-1100.

  27. Fisher E, Siemens H, Pund R, Wittfoth W, Nau H. Valproate Metabolites in during Antiepileptic Teraphy in children with Infantile Spasms: Abnormal Metabolite Pattern Associated with Reversible Hepatotoxicity. Epilepsia 1991; 32: 165-70.

  28. Chadwick D. Valproate in the Treatment of Partial Epilepsies. Epilepsia 1994; 35: S96-S98.

  29. Suzuki A, Aso K, Ariyoshi Ch, Ishimaru M. Acute Intermittent Porphyria and Epilepsy: Safety of Clonazepam. Epilepsia 1992; 33: 108-11.

  30. Homan R, Rosengerg H. Benzodiazepines. En: Elaine W. ed. The treatment of Epilepsy: Principles and practice. Filadelfia-London: Lea and Febiger 1993; 79: 932-49.

  31. Snead O. ACTH. En: Elaine W, ed. The treatment of Epilepsy: Principles and practice. Filadelfia-London. Lea and Febiger 1993; 80: 950-4.




2020     |     www.medigraphic.com